LabGenomics Co (XKRX:084650) Total Liabilities : ₩76,659 Mil (As of Sep. 2024)

View and export this data going back to 2013. Start your Free Trial

What is LabGenomics Co Total Liabilities?

LabGenomics Co's Total Liabilities for the quarter that ended in Sep. 2024 was ₩76,659 Mil.

LabGenomics Co's quarterly Total Liabilities declined from Mar. 2024 (₩84,707.49 Mil) to Jun. 2024 (₩78,737.88 Mil) and declined from Jun. 2024 (₩78,737.88 Mil) to Sep. 2024 (₩76,659.34 Mil).

LabGenomics Co's annual Total Liabilities declined from Dec. 2021 (₩45,865.31 Mil) to Dec. 2022 (₩40,142.38 Mil) but then increased from Dec. 2022 (₩40,142.38 Mil) to Dec. 2023 (₩85,314.34 Mil).

LabGenomics Co Total Liabilities Historical Data

The historical data trend for LabGenomics Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LabGenomics Co Total Liabilities Chart

LabGenomics Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

19,060.53

27,723.23

45,865.31

40,142.38

85,314.34

LabGenomics Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Liabilities	Get a 7-Day Free Trial															98,558.94	85,314.34	84,707.49	78,737.88	76,659.34

LabGenomics Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

LabGenomics Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	65054.919	+	(18785.504	+	1473.914
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	85,314

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	313457.036	-	228142.699
	=	85,314

LabGenomics Co's Total Liabilities for the quarter that ended in Sep. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	74663.03	+	(1856.305	+	140.00000000001
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	76,659

Total Liabilities	=	Total Assets (Q: Sep. 2024 )	-	Total Equity (Q: Sep. 2024 )
	=	295293.462	-	218634.127
	=	76,659

LabGenomics Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of LabGenomics Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

LabGenomics Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LabGenomics Co Ltd (XKRX:084650) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

700 Daewangpangyo-ro, 6F-B, Bundang-gu, Korea Bio Park Building, Gyeonggi-do, Seongnam, KOR, 463-400

Website

http://www.labgenomics.co.kr

LabGenomics Co Ltd is a healthcare company. The Company operates in three business divisions namely NGS, Diagnostic service, IVD products. NGS offers mom guard, cancer panel, Predisposition panel and PGS; Diagnostic service provides esoteric tests such as cancer genetics, genetic disorder. Whereas IVD products include DNA chips, PCR kit among others.

LabGenomics Co Headlines

No Headlines